Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes Print E-mail

 

 

Vaccine. 2006 Nov 10;24(44-46):6670-4. Epub 2006 Jun 6.

 

Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial.

 

de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J. Institute of Physiology and Biochemistry of Nutrition, Federal Research Centre of Nutrition and Food, Hermann-Weigmann-Strasse 1, D-24103 Kiel, Germany. devrese@bafm.de

 

To investigate the effect of long-term consumption of probiotic bacteria on viral respiratory tract infections (common cold, influenza), a randomized, double blind, controlled intervention study was performed during two winter/spring periods (3 and 5 month). Four hundred and seventy-nine healthy adults were supplemented daily with vitamins plus minerals with or without probiotic lactobacilli and bifidobacteria. The intake of the probiotic had no effect on the incidence of common cold infections (verum=158, control=153 episodes, influenza was not observed), but significantly shortened duration of episodes by almost 2 days (7.0+/-0.5 versus 8.9+/-1.0 days, p=0.045), reduced the severity of symptoms and led to larger increases in cytotoxic T plus T suppressor cell counts and in T helper cell counts.

 

PMID: 16844267 [PubMed - indexed for MEDLINE]


Full Article Available Online

 

 

 

{mosgoogle}

 

{mos_sb_discuss:11}

 


 

Comments (0)Add Comment

Write comment

busy
 

 

Latest Comments

EiR on Facebook

Follow us on Facebook

EiR on Google+



EiR on Twitter


Follow The EiR on Twitter

Online Members

0 users online